// July 11, 2022
USP Convention Series: The supply chain imperative to fight AMR by conserving today’s...
The problem of AMR is likely to have become significantly worse with the reportedly massive inappropriate use of antibiotics over the course of the COVID-19 pandemic, along with the likely increase in the prevalence of poor-quality antimicrobials resulting from supply chain quality concerns.
// June 23, 2022
How medicine quality affects antimicrobial resistance and the medicines supply chain ...
Learn how medicine quality affects antimicrobial resistance and the medicines supply chain
// June 22, 2022
Avoid product recalls - Know your impurities
Impurities are any components that are not active ingredients or excipients, and that can compromise quality in a drug substance or product. Pharmaceutical impurities can be classified as organic or inorganic and include residual solvents. The presence of impurities results from manufacturing and degradation processes.
// June 09, 2022
Pharmaceutical continuous manufacturing: What drug makers need to know...
Pharmaceutical continuous manufacturing (PCM) technology has gained increased attention from industry and policymakers as one way to help expand domestic manufacturing of essential medicines